Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Arbyn

Showing results (281-290 of 309) with videos related to

Pageof 31
Sort By:
International Journal of Cancer|May 25, 2012
EUROGIN 2011 roadmap on prevention and treatment of HPV-related diseaseMarc Arbyn, Silvia de Sanjosé, Mona Saraiya, et al.
Cancer Cytopathology|September 11, 2015
Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesionPaolo Giorgi Rossi, Guglielmo Ronco, Joakim Dillner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2021
2020 list of human papillomavirus assays suitable for primary cervical cancer screeningMarc Arbyn, Marie Simon, Eliana Peeters, et al.
Epidemiologia E Prevenzione|July 26, 2012
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]Guglielmo Ronco, Annibale Biggeri, Massimo Confortini, et al.
Molecular Oncology|November 18, 2025
European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancerMangesh A Thorat, Marc Arbyn, David Baldwin, et al.
Cancer Epidemiology|February 21, 2016
Surveillance of effects of HPV vaccination in BelgiumMarc Arbyn, Davy Vanden Broeck, Ina Benoy, et al.
Nature Reviews. Clinical Oncology|September 2, 2015
HPV-FASTER: broadening the scope for prevention of HPV-related cancerF Xavier Bosch, Claudia Robles, Mireia Díaz, et al.
Molecular Oncology|January 16, 2026
European Code Against Cancer, 5th edition - organised cancer screening programmesEsther Toes-Zoutendijk, Marc Arbyn, Anssi Auvinen, et al.
Nature Medicine|December 12, 2023
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIVMichaela T Hall, Kate T Simms, John M Murray, et al.
Journal of Medical Virology|September 2, 2024
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screeningMarc Arbyn, Kate Cuschieri, Jesper Bonde, et al.
Pageof 31

Showing results (281-290 of 309) with videos related to

Sort By:
Pageof 31
International Journal of Cancer|May 25, 2012
EUROGIN 2011 roadmap on prevention and treatment of HPV-related diseaseMarc Arbyn, Silvia de Sanjosé, Mona Saraiya, et al.
Cancer Cytopathology|September 11, 2015
Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesionPaolo Giorgi Rossi, Guglielmo Ronco, Joakim Dillner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2021
2020 list of human papillomavirus assays suitable for primary cervical cancer screeningMarc Arbyn, Marie Simon, Eliana Peeters, et al.
Epidemiologia E Prevenzione|July 26, 2012
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]Guglielmo Ronco, Annibale Biggeri, Massimo Confortini, et al.
Molecular Oncology|November 18, 2025
European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancerMangesh A Thorat, Marc Arbyn, David Baldwin, et al.
Cancer Epidemiology|February 21, 2016
Surveillance of effects of HPV vaccination in BelgiumMarc Arbyn, Davy Vanden Broeck, Ina Benoy, et al.
Nature Reviews. Clinical Oncology|September 2, 2015
HPV-FASTER: broadening the scope for prevention of HPV-related cancerF Xavier Bosch, Claudia Robles, Mireia Díaz, et al.
Molecular Oncology|January 16, 2026
European Code Against Cancer, 5th edition - organised cancer screening programmesEsther Toes-Zoutendijk, Marc Arbyn, Anssi Auvinen, et al.
Nature Medicine|December 12, 2023
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIVMichaela T Hall, Kate T Simms, John M Murray, et al.
Journal of Medical Virology|September 2, 2024
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screeningMarc Arbyn, Kate Cuschieri, Jesper Bonde, et al.
Pageof 31